Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Appelbaum

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|March 20, 1986
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemiaR Storb, H J Deeg, J Whitehead, et al.
Blood|July 1, 1986
Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host diseaseR Storb, H J Deeg, V Farewell, et al.
Experimental Hematology|October 1, 1989
Specific marrow localization of an 131I-labeled anti-myeloid antibody in normal dogs: effects of a "cold" antibody pretreatment dose on marrow localizationJ A Bianco, B Sandmaier, P A Brown, et al.
Blood|May 1, 1989
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trialR Storb, H J Deeg, M Pepe, et al.
Blood|February 1, 1988
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trialsR Storb, H J Deeg, L Fisher, et al.
Seminars in Hematology|July 1, 1991
Marrow transplantation for severe aplastic anemia and thalassemia majorR Storb, C Anasetti, F Appelbaum, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1993
Samarium-153-EDTMP biodistribution and dosimetry estimationJ F Eary, C Collins, M Stabin, et al.
Blood|April 1, 1986
Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantationK M Sullivan, H J Deeg, J Sanders, et al.
Blood|May 1, 1994
Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemiaR Storb, W Leisenring, H J Deeg, et al.
British Journal of Haematology|August 1, 1989
Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trialR Storb, H J Deeg, M Pepe, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|March 20, 1986
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemiaR Storb, H J Deeg, J Whitehead, et al.
Blood|July 1, 1986
Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host diseaseR Storb, H J Deeg, V Farewell, et al.
Experimental Hematology|October 1, 1989
Specific marrow localization of an 131I-labeled anti-myeloid antibody in normal dogs: effects of a "cold" antibody pretreatment dose on marrow localizationJ A Bianco, B Sandmaier, P A Brown, et al.
Blood|May 1, 1989
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trialR Storb, H J Deeg, M Pepe, et al.
Blood|February 1, 1988
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trialsR Storb, H J Deeg, L Fisher, et al.
Seminars in Hematology|July 1, 1991
Marrow transplantation for severe aplastic anemia and thalassemia majorR Storb, C Anasetti, F Appelbaum, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1993
Samarium-153-EDTMP biodistribution and dosimetry estimationJ F Eary, C Collins, M Stabin, et al.
Blood|April 1, 1986
Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantationK M Sullivan, H J Deeg, J Sanders, et al.
Blood|May 1, 1994
Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemiaR Storb, W Leisenring, H J Deeg, et al.
British Journal of Haematology|August 1, 1989
Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trialR Storb, H J Deeg, M Pepe, et al.
Pageof 7